Olympus Capital Asia Exits Aster DM Healthcare with Rs 1,978 Cr Stake Sale

New Delhi, Mar 27 - In a significant move within the healthcare and investment sectors, Olympus Capital Asia, a leading private equity firm, has divested a 9.8 per cent stake in Aster DM Healthcare. The transaction, valued at Rs 1,978 crore, was executed through open market transactions on Wednesday. This strategic sale involved more than 4.88 crore shares of the Dubai-based healthcare giant, Aster DM Healthcare.

Representative image

Olympus Capital Asia carried out the sale via its two affiliates, Olympus Capital Asia Investments Ltd and Olympus ACF Pte Ltd. Detailed bulk deal data from the Bombay Stock Exchange (BSE) revealed that Olympus Capital Asia Investments offloaded over 4.42 crore equity shares, while Olympus ACF Pte Ltd sold around 45.59 lakh shares of Aster DM Healthcare. The shares were sold at a price range between Rs 405 and Rs 406.72 each, culminating in a total transaction value of Rs 1,978.35 crore.

As of December 2023, Olympus Capital Asia Investments Ltd held an 18.96 per cent stake in Aster DM Healthcare, as per the shareholding data available with the BSE. This divestment marks a notable adjustment in the firm's investment portfolio.

In related market activity, several prominent investment entities including Capital Group through its affiliate SmallCap World Fund Inc, SBI Mutual Fund MF, Nippon India MF, and ICICI Prudential MF acquired nearly 3.13 crore shares of Aster DM Healthcare. This acquisition comes amidst a notable dip in Aster DM Healthcare's share price, which fell by 7.28 per cent to close at Rs 404.85 apiece on the BSE.

In another noteworthy transaction on the BSE, financial services conglomerate Capital Group acquired shares of Aditya Vision for Rs 95 crore through open market transactions. The purchase involved more than 2.81 lakh shares, representing a 2.2 per cent stake in Aditya Vision at an average price of Rs 3,400 per share. The deal size amounted to Rs 95.71 crore.

Simultaneously, Sunita Sinha and Rashi Vardhan, promoters of Aditya Vision Ltd, also disposed of their shares at the same price point. Following these transactions, Aditya Vision's stock experienced a positive movement, rising by 1.98 per cent to settle at Rs 3,367.40 each on the BSE.

These transactions highlight significant shifts within the investment landscape of India's healthcare and retail sectors. They reflect not only the dynamic nature of market investments but also underscore the strategic realignments by major stakeholders in response to evolving market conditions.